IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
Conditions: Diabetes Mellitus Type 2 in Obese; Inflammation; Metabolic Disease; Glucose Metabolism Disorders (Including Diabetes Mellitus) Intervention: Drug: Anakinra Prefilled Syringe Sponsor: University Hospital, Basel, Switzerland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Hospitals | Insulin | Obesity | Research | Switzerland Health